Skip to main content
AtriCure, Inc. logo

AtriCure, Inc. — Investor Relations & Filings

Ticker · ATRC ISIN · US04963C2098 LEI · 254900B2I6GPHK2EXM59 US Manufacturing
Open in API
Filings indexed 1,189 across all filing types
Latest filing 2017-08-18 Investor Presentation
Country US United States of America
Listing US ATRC

About AtriCure, Inc.

https://www.atricure.com

AtriCure, Inc. is a medical device company focused on developing, manufacturing, and selling technologies for the treatment of atrial fibrillation (Afib), management of the left atrial appendage (LAA), and post-operative pain. The company's product portfolio is primarily utilized by cardiothoracic surgeons and electrophysiologists. Key offerings include surgical ablation systems and the AtriClip® LAA Exclusion System, a widely implanted device for LAA management. Additionally, AtriCure provides cryoablation technology, such as the cryoXT™ Probe, which offers a non-opioid approach to pain management following surgical procedures, including amputation.

Recent filings

Filing Released Lang Actions
8-K
Investor Presentation Classification · 95% confidence The document is a Form 8-K filed with the SEC, dated August 18, 2017, by AtriCure, Inc. It primarily announces the posting of an investor presentation on the company's website and includes the presentation as Exhibit 99.1. The text explicitly states that the presentation is furnished and incorporated by reference, and the document is a current report under the Securities Exchange Act of 1934. The content focuses on disclosing an investor presentation with financial results and forward-looking statements, but does not contain the full presentation text or detailed financial statements itself. The document length is 4797 characters, which is relatively short and consistent with an announcement rather than the full report. According to the classification rules, announcements of presentations or reports that are short and provide links or references to the full document should be classified as Investor Presentation (IP) if the document itself is the presentation, or Report Publication Announcement (RPA) if it is only announcing the report. However, since the presentation is furnished as an exhibit and incorporated by reference, and the document is a Form 8-K current report announcing the investor presentation, the best fit is Investor Presentation (IP).
2017-08-18 English
FORM 4 SUBMISSION
Director's Dealing
2017-08-03 English
S-8
Regulatory Filings Classification · 95% confidence The document is a Form S-8 Registration Statement filed with the SEC, which is used for registering securities to be offered under employee benefit plans such as stock incentive plans. It includes details about the stock plan, indemnification provisions for directors and officers, and references to other filings like the Annual Report on Form 10-K and Quarterly Reports on Form 10-Q. This is a regulatory filing related to securities registration, not a financial report, earnings release, or management discussion. It does not fit into categories like Annual Report (10-K), Earnings Release (ER), or Proxy Solicitation (PSI). The best fitting category is Regulatory Filings (RNS), which is the fallback for miscellaneous SEC filings that do not fit other specific categories.
2017-07-28 English
10-Q
Interim / Quarterly Report Q2 2017
2017-07-28 English
8-K
Earnings Release Classification · 95% confidence The document is a Form 8-K filed with the SEC, dated July 27, 2017, reporting the results of operations and financial condition for the second quarter ended June 30, 2017. It includes a press release about financial results and mentions a conference call to discuss these results. The document is relatively short (3692 characters) and primarily serves as a current report to announce financial results and a related press release. It does not contain the full financial statements or detailed financial analysis itself, but rather references the press release and conference call. This type of filing is best classified as an Earnings Release (ER), which is the initial announcement of quarterly financial results with key highlights only.
2017-07-27 English
FORM 4 SUBMISSION
Director's Dealing
2017-07-25 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.